Managing the Impact of Cronobacter sakazakii , the Nemesis of Powdered Formula
J Pediatr Gastroenterol Nutr
.
2022 Aug 1;75(2):113-115.
doi: 10.1097/MPG.0000000000003508.
Epub 2022 Jun 6.
Authors
Timothy Sentongo
1
,
Desiree Sierra Velez
2
,
Phuong Huynh
3
,
Ruba Abdelhadi
4
,
Alvin Chan
5
,
Praveen Goday
6
,
Sara Karjoo
7
,
Sivan Kinberg
8
,
Russell Merritt
9
,
Nikhil Pai
10
,
Ruben E Quiros-Tejeira
11
,
Debora Duro
12
Affiliations
1
From the University of Chicago, Chicago, IL.
2
the University of California, San Francisco, CA.
3
the Boston Children's Hospital, Boston, MA.
4
the Children's Mercy Hospital, Kansas City, MO.
5
the University of California, Los Angeles, CA.
6
the Medical College of Wisconsin, Milwaukee, WI.
7
the John Hopkins Medicine, St Petersburg, FL.
8
the Columbia University, NY.
9
the Children's Hospital of Los Angeles, Los Angeles, CA.
10
the McMaster University, Hamilton ON, Canada.
11
the University of Nebraska, Omaha, NE.
12
the Broward Health, Fort Lauderdale, FL.
PMID:
35666843
DOI:
10.1097/MPG.0000000000003508
No abstract available
MeSH terms
Cronobacter sakazakii*
Cronobacter*
Food, Formulated
Humans
Infant
Infant Formula
Powders
Substances
Powders